ArticleNPJ breast cancer2023

Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer.

Helena Record et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.